Evidence map›Paper›PMID 35968712›Full record

ArticleCirculation research2022

Targeting SIRT1 Rescues Age- and Obesity-Induced Microvascular Dysfunction in Ex Vivo Human Vessels.

Alessandro Mengozzi, Sarah Costantino, Francesco Paneni, Emiliano Duranti, Monica Nannipieri, Rudj Mancini, Michele Lai, Veronica La Rocca, Ilaria Puxeddu, Luca Antonioli and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Targeting the Epigenetic Remodeler GCN5 Prevents Vascular Oxidative Stress and Endothelial Dysfunction in Obesity: Insights in Patients with Cardiometabolic Disease.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2025
    Article
  18. How to measure and model cardiovascular aging.Cardiovascular research · 2025
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 10 institutions in 7 countries.

Alessandro Mengozzi *Department of Clinical and Experimental Medicine (A.M., E.D., M.N., I.P., L.A., M.F., C.I., N.B., N.R.P., S.T., A.V., S.M.), University of Pisa, Italy.ORCID 0000-0003-2834-9725
Sarah Costantino *Center for Molecular Cardiology, University of Zürich, Switzerland (S.C., F.P.).
Francesco PaneniCenter for Molecular Cardiology, University of Zürich, Switzerland (S.C., F.P.).
Emiliano DurantiDepartment of Clinical and Experimental Medicine (A.M., E.D., M.N., I.P., L.A., M.F., C.I., N.B., N.R.P., S.T., A.V., S.M.), University of Pisa, Italy.
Monica NannipieriDepartment of Clinical and Experimental Medicine (A.M., E.D., M.N., I.P., L.A., M.F., C.I., N.B., N.R.P., S.T., A.V., S.M.), University of Pisa, Italy.ORCID 0000-0003-1346-2813
Rudj ManciniUnit of Bariatric Surgery, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy (R.M.).
Michele LaiRetrovirus Center and Virology Section, Department of Translational Research and New Technologies in Medicine and Surgery (M.L., V.L.R.), University of Pisa, Italy.ORCID 0000-0001-7597-123X
Veronica La RoccaRetrovirus Center and Virology Section, Department of Translational Research and New Technologies in Medicine and Surgery (M.L., V.L.R.), University of Pisa, Italy.ORCID 0000-0002-4317-7100
Ilaria PuxedduDepartment of Clinical and Experimental Medicine (A.M., E.D., M.N., I.P., L.A., M.F., C.I., N.B., N.R.P., S.T., A.V., S.M.), University of Pisa, Italy.
Luca AntonioliDepartment of Clinical and Experimental Medicine (A.M., E.D., M.N., I.P., L.A., M.F., C.I., N.B., N.R.P., S.T., A.V., S.M.), University of Pisa, Italy.
Matteo FornaiDepartment of Clinical and Experimental Medicine (A.M., E.D., M.N., I.P., L.A., M.F., C.I., N.B., N.R.P., S.T., A.V., S.M.), University of Pisa, Italy.
Marco GhionzoliPaediatric Surgery Unit, Meyer Children's Hospital, Florence, Italy (M.G.).
Georgios GeorgiopoulosSchool of Biomedical Engineering and Imaging Sciences, King's College London, United Kingdom (G.G.).
Chiara IppolitoDepartment of Clinical and Experimental Medicine (A.M., E.D., M.N., I.P., L.A., M.F., C.I., N.B., N.R.P., S.T., A.V., S.M.), University of Pisa, Italy.
Nunzia BernardiniDepartment of Clinical and Experimental Medicine (A.M., E.D., M.N., I.P., L.A., M.F., C.I., N.B., N.R.P., S.T., A.V., S.M.), University of Pisa, Italy.
Frank RuschitzkaDepartment of Cardiology, University Heart Center (F.P., F.R.), University Hospital Zurich, Switzerland.
Nicola Riccardo PuglieseDepartment of Clinical and Experimental Medicine (A.M., E.D., M.N., I.P., L.A., M.F., C.I., N.B., N.R.P., S.T., A.V., S.M.), University of Pisa, Italy.ORCID 0000-0002-5473-227X
Stefano TaddeiDepartment of Clinical and Experimental Medicine (A.M., E.D., M.N., I.P., L.A., M.F., C.I., N.B., N.R.P., S.T., A.V., S.M.), University of Pisa, Italy.ORCID 0000-0002-5002-3070
Agostino Virdis *Department of Clinical and Experimental Medicine (A.M., E.D., M.N., I.P., L.A., M.F., C.I., N.B., N.R.P., S.T., A.V., S.M.), University of Pisa, Italy.
Stefano Masi *Department of Clinical and Experimental Medicine (A.M., E.D., M.N., I.P., L.A., M.F., C.I., N.B., N.R.P., S.T., A.V., S.M.), University of Pisa, Italy.ORCID 0000-0002-7591-3686
Anna Needs Neuroblastoma Answers · USUniversity of Pisa · ITMACOM (United States) · USScuola Superiore Sant'Anna · ITUniversity Hospital of Zurich · CHAzienda Ospedaliera Universitaria Pisana · ITCardiovascular Institute of the South · USCenter for Pediatric Endocrinology Zurich · CHKing's College London · GBMeyer Children's Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExperimental evidence suggests a key role of SIRT1 (silent information regulator 1) in age- and metabolic-related vascular dysfunction. Whether these effects hold true in the human microvasculature is unknown. We aimed to investigate the SIRT1 role in very early stages of age- and obesity-related microvascular dysfunction in humans.

methodsNinety-five subjects undergoing elective laparoscopic surgery were recruited and stratified based on their body mass index status (above or below 30 kg/m

resultsCompared with Young Nonobese, obese and older patients showed lower vascular expression of SIRT1 and antioxidant proteins (FOXO3 [forkhead box protein O3] and SOD2) and higher expression of pro-oxidant and aging mitochondria proteins p66

conclusionsSIRT1 is a novel central modulator of the earliest microvascular damage induced by age and obesity. Through a complex epigenetic control mainly involving p66

Indexed as

ArginaseObesitySirtuin 1Vascular DiseasesAdultEpigenesis, GeneticHumansMitochondrial ProteinsNitric OxideReactive Oxygen SpeciesArginaseMitochondrial ProteinsNitric OxideReactive Oxygen SpeciesSIRT1 protein, humanSirtuin 1agingendothelial cellsmicrocirculationmitochondriaobesitysirtuins

Identifiers

PMID35968712
PMCPMC9426744
OpenAlexW4291778732

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.